Hospital
Holmes Regional Medical Center, INC
Holmes Regional Medical Center, INC was paid $7.24M by Medicaid between Jan 2018 and Nov 2024, across 156 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoHOLMES REGIONAL MEDICAL CENTER, INC
PALM BAY, FL 32907
PALM BAY, FL 32907
33aNPI1386940823assigned 02/01/2011
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.24M
24GClaims355,013
24DCodes billed156
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#68 of 163
Median peer was paid$4.77M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PULIO, KRISTEN controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,380 | $422K | |
| 2019 | 76,973 | $1.02M | |
| 2020 | 60,347 | $738K | |
| 2021 | 69,916 | $1.16M | |
| 2022 | 76,742 | $1.96M | |
| 2023 | 34,379 | $1.43M | |
| 2024incomplete | 8,276 | $513K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 20,918 | 18,590 | $1.92M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 20,565 | 19,046 | $1.79M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 11,762 | 10,026 | $1.19M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 3,644 | 3,402 | $300K |
| 80053 | Comprehensive metabolic panel | 2.8% | 23,670 | 19,642 | $200K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 2,915 | 2,632 | $174K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 4,515 | 3,793 | $149K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 16,806 | 12,234 | $139K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 1,742 | 1,540 | $129K |
| 87430 | 1.5% | 2,410 | 2,320 | $107K | |
| 87400 | 1.2% | 2,839 | 2,575 | $90K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,495 | 1,923 | $53K |
144 more codes
| 84484 | <1% | 7,006 | $49K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 535 | $47K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,443 | $46K |
| 87088 | <1% | 4,895 | $43K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,059 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,567 | $36K |
| 99218 | <1% | 1,874 | $34K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 464 | $34K |
| 81001 | <1% | 10,764 | $32K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,565 | $31K |
| 73610 | <1% | 749 | $30K | |
| 87486 | <1% | 2,850 | $28K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 3,321 | $27K |
| 73630 | <1% | 937 | $25K | |
| 73562 | <1% | 781 | $25K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,975 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 642 | $23K |
| 73030 | <1% | 504 | $17K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 782 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,669 | $16K |
| A9270 | Non-covered item or service | <1% | 25,660 | $16K |
| 73130 | <1% | 600 | $15K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 499 | $13K |
| 87210 | <1% | 1,725 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,654 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,521 | $11K |
| 81003 | <1% | 2,385 | $11K | |
| 81025 | <1% | 2,314 | $11K | |
| 73110 | <1% | 371 | $11K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,546 | $11K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 263 | $10K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,383 | $10K |
| 86900 | <1% | 1,293 | $10K | |
| 93975 | <1% | 800 | $10K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 298 | $10K |
| 94760 | <1% | 2,881 | $8K | |
| 93041 | <1% | 6,893 | $8K | |
| 87040 | <1% | 3,137 | $8K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 49 | $8K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,353 | $8K |
| 85610 | <1% | 4,246 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 394 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,793 | $7K |
| 94664 | <1% | 1,870 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 425 | $6K |
| 85027 | <1% | 6,192 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,843 | $6K |
| 83690 | <1% | 4,966 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,620 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,017 | $5K |
| 85730 | <1% | 3,306 | $5K | |
| 72100 | <1% | 254 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 450 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,037 | $4K |
| 80061 | Lipid panel | <1% | 2,191 | $4K |
| 73080 | <1% | 72 | $4K | |
| 73140 | <1% | 58 | $4K | |
| 83605 | <1% | 3,192 | $4K | |
| 86850 | <1% | 383 | $3K | |
| 93971 | <1% | 268 | $3K | |
| 87077 | <1% | 360 | $3K | |
| 84702 | <1% | 1,054 | $3K | |
| 82947 | <1% | 247 | $3K | |
| 82962 | <1% | 292 | $3K | |
| J2704 | Injection, propofol, 10 mg | <1% | 664 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 28 | $3K |
| 87420 | <1% | 476 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,115 | $3K |
| 85379 | <1% | 1,595 | $3K | |
| 84703 | <1% | 5,188 | $3K | |
| 83880 | <1% | 1,727 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 165 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 178 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,321 | $2K |
| 76801 | <1% | 566 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 439 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,184 | $2K |
| 87631 | <1% | 44 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,156 | $2K |
| 96376 | <1% | 1,290 | $1K | |
| 78580 | <1% | 17 | $1K | |
| 83735 | <1% | 2,223 | $1K | |
| 86308 | <1% | 238 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,098 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,812 | $1K |
| 73502 | <1% | 63 | $973.73 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 513 | $913.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 461 | $898.54 |
| 87186 | <1% | 1,684 | $857.40 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,852 | $850.11 |
| 86901 | <1% | 1,287 | $823.50 | |
| 87581 | <1% | 2,848 | $715.87 | |
| 87081 | <1% | 2,255 | $706.16 | |
| 71250 | <1% | 15 | $651.01 | |
| 93017 | <1% | 28 | $638.22 | |
| 82550 | <1% | 368 | $549.08 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 189 | $509.33 |
| 87205 | <1% | 47 | $426.91 | |
| 73090 | <1% | 40 | $423.11 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 901 | $389.71 |
| 82607 | <1% | 280 | $383.64 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 995 | $378.60 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 360 | $349.49 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 549 | $327.64 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 859 | $299.72 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,833 | $289.19 |
| 90715 | <1% | 144 | $279.22 | |
| 86140 | <1% | 279 | $277.75 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $238.48 |
| 87071 | <1% | 47 | $218.74 | |
| 85007 | <1% | 657 | $166.36 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 116 | $135.55 |
| 97161 | <1% | 16 | $128.58 | |
| 85055 | <1% | 51 | $99.41 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 273 | $99.38 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 22 | $96.91 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 274 | $92.93 |
| 74018 | <1% | 12 | $77.22 | |
| 72131 | <1% | 34 | $74.40 | |
| 82746 | <1% | 62 | $72.49 | |
| 84439 | <1% | 51 | $57.77 | |
| 85652 | <1% | 239 | $54.08 | |
| 82077 | <1% | 381 | $53.11 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 29 | $49.44 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 219 | $23.30 |
| 82043 | <1% | 15 | $6.81 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 242 | $1.08 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 140 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 57 | $0.00 |
| 80143 | 0% | 98 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 105 | $0.00 |
| 80179 | 0% | 98 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 13 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 361 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 16 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 58 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 26 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 13 | $0.00 |
| 82553 | 0% | 12 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 15 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 12 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 14 | $0.00 |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPULIO, KRISTEN (EVP CFO)
Parent organizationHOLMES REGIONAL MEDICAL CENTER, INC.
| Provider | Location | Paid |
|---|---|---|
| Holmes Regional Medical Center, INC. | Melbourne, FL | $12.33M |
| Adventist Healthcare Fort Washington Medical Center INC | Ft Washington, MD | $8.63M |
| Hospice of Health First INC. | West Melbourne, FL | $4.13M |
| Cape Canaveral Hospital, INC. | Cocoa Beach, FL | $3.66M |
| Viera Hospital INC | Melbourne, FL | $2.04M |
| Blackwell Physicians, LLC | Rockville, MD | $1.94M |
| Adventist Physician Services, INC. | Rockville, MD | $405K |
| Adventist Physician Services, INC. | Takoma Park, MD | $79K |
| Holmes Regional Medical Center, INC. | Melbourne, FL | $25K |
| Adventist Physician Services, INC. | Germantown, MD | $5K |
| Doctors Gi Partnership LTD | Palm Bay, FL | $932.71 |
| Cape Canaveral Hospital, INC. | Melbourne, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.